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Background/aim: Popliteal artery aneurysms (PAAs) are abnormal bulgings, which account for 70% of all peripheral artery aneurysms.
They are usually asymptomatic. In this study, we present our long-term results of endovascular stent grafts in the treatment of PAA in
the light of literature data.
Material and methods: A total of 63 legs of 63 patients with PAA, who were treated with endovascular techniques in our clinic between
July 2010 and July 2019, were retrospectively analyzed. All patients underwent color Doppler ultrasound (DUS), magnetic resonance
angiography (MRA), or computed tomography angiography (CTA) to identify the diameter and length of PAAs, vessel tortuosity,
the presence and degree of thrombus, and diameter in the healthy landing zone and to visualize tibioperoneal vascular structures. A
Viabahn stent graft was inserted in all patients.
Results: 57 patients (90.5%) were males with a mean age of 76.35 ± 7 years. 24 patients (38.1%) were symptomatic, while 11 patients
(17.5%) had a concomitant abdominal aortic aneurysm (AAA). The mean follow-up period was 46.05 ± 25.01 months. The primary
patency rate was 79.3%. A graft thrombosis was observed in 13 patients (20.6%) during a mean follow-up period of 8.31 ± 5.91 months.
The number of distal arteries was significantly lower in the patients with thrombosis than those without.
Conclusions: Endovascular treatment of PAA using stentgrafts is safe in selected cases. However, it is reasonable to avoid endovascular
treatment due to an increased risk for thrombosis in patients with a low number of patent distal arteries or impaired distal flow.
Key words: Peripheral, vascular, stenting, aneurysm

1. Introduction
Popliteal artery aneurysms (PAAs) are abnormal bulgings,
which occur in the wall of the blood vessel and account
for 70% of all peripheral artery aneurysms. The prevalence
of PAAs has been estimated as 1% in men aged between
60 and 80 years. [1] They mostly affect male sex with a
male-to-female ratio of 20:1. [2] The majority of PAAs
are asymptomatic and diagnosis is usually made based
on the presence of a wide arterial pulse in the popliteal
fossa region on palpation during physical examination
or coincidentally by imaging modalities used for other
reasons.
The natural course of the disease includes both acute
and chronic thromboembolic complications. Nearly
half of patients with chronic thromboembolism present
with intermittent claudication, rest pain, and/or acral
necrosis. [3] Although PAA rupture is uncommon, acute
thrombosis and distal embolization may be present in 30%

of cases, increasing the amputation rate up to 20% [4,5].
Irrespective of the aneurysm diameter, all symptomatic
PAAs and asymptomatic cases with an aneurysm diameter
of >2 cm along with a severe mural thrombus and poor
infrapopliteal arterial run-off are recommended to be
treated. [6]
Doppler ultrasound (DUS), magnetic resonance
angiography (MRA), computed tomography angiography
(CTA), and conventional angiography are the most
commonly used diagnostic tools. Surgical repair with a
saphenous vein graft or synthetic graft is the gold standard
in the treatment of PAAs. [6] However, after the first
successful endovascular repair of a ruptured abdominal
aortic aneurysm (AAA) was performed by Marin et al.
[7] in 1994, endovascular treatment has been increasingly
adopted among surgeons, particularly for high-risk
patients for surgery and for those refusing a surgical
intervention. The main advantages of endovascular repair
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include shorter operation duration, potential avoidance
of general anesthesia, possibility of bilateral intervention
in a single session, shorter length of hospital stay, and less
perioperative mortality [8,9].
On the other hand, no consensus on endovascular
treatment of PAAs has been reached, yet. In this study, we
present our long-term results of endovascular stent grafts
in the treatment of PAA and to provide in the light of
literature data.
2. Materials and methods
2.1. Study design and study population
This single-center, retrospective study included a total
of 63 legs of 63 patients with PAA who were treated
with endovascular techniques in our clinic between
July 2010 and July 2019. Data including demographic
and clinical characteristics and aneurysm and operative
data were recorded. Asymptomatic patients with an
aneurysm diameter of >20 mm were also included. The
main complaints of symptomatic patients on admission
include persistent knee pain, venous pressure symptoms,
claudication, and bulging behind the knee joint. A written
informed consent was obtained from each patient.
The study protocol was approved by the local Ethics
Committee. The study was conducted in accordance with
the principles of the Declaration of Helsinki.
All patients underwent color DUS, MRA, or CTA to
identify the diameter and length of PAAs, vessel tortuosity,
the presence and degree of thrombus, and vessel
diameter in the healthy landing zone and to visualize
tibioperoneal vascular structures (Figure 1). Patients
with severe atherosclerotic occlusive disease at the level
of iliac and femoral arteries, without an adequate and
appropriate distal and proximal landing zone, and those
with unsuitable tibioperoneal anatomy were considered
ineligible for endovascular treatment and excluded.
2.2. Endovascular technique
All procedures were performed under spinal or local
anesthesia in the angiography laboratory by experienced
surgeons. A 7Fr or 9Fr sheath was inserted to the femoral
artery through percutaneous access, while ≥10Fr sheath
was reserved for surgical access. All patients received
5000 IU standard heparin after the procedure. Computed
tomography angiography was performed to identify the
size and location of PAA and vessel size and diameter
in the healthy landing zone (Figure 2). A 0.035-inch
guidewire was then inserted into the vessel lumen for
stent graft implantation. A Viabahn stent graft (W.L. Gore
& Associates Inc., Flagstaff, AZ, USA) was inserted in all
patients (Figure 3). The diameter and length of the stent
graft to be used were chosen based on precise MRA or
CTA measurements preoperatively. The diameter of the
graft to be used was selected as exceeding the luminal

Figure 1. Preoperative magnetic resonance angiography image
showing a popliteal aneurysm.

diameter by 10 to 15%. For the use of multiple stent grafts,
distal stents were placed initially and proximal stents were
then placed, providing an overlap by a minimum of 20
mm. After stenting, balloon dilatation was performed.
Technical success was defined as the elimination of
aneurysm without endoleak and with intact distal flow
(Figure 4). Following the procedure, a loading dose of
clopidogrel 300 mg was given to all patients, followed by
75 mg clopidogrel and 100 mg acetylsalicylic acid daily.
Treatment modification was avoided in patients using oral
anticoagulants for other indications. For this technique,
appropriate proximal and distal stent landing zones and
patent distal tibioperoneal arteries should be met. And
also, increased aneurysm length is a disadvantage for
endovascular repair. The diameter and length of the stents
should be chosen carefully. During the postoperative
follow-up period, it should be ensured that patients receive
correct and sufficient antiaggregant treatment.
2.3. Postoperative follow-up
All patients were followed at one, six, and 12 months for
the first year and annually thereafter using CTA. During
follow-up, stent graft fractures and graft thrombosis were
evaluated through conventional angiography for patients
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Figure 3. A Viabahn stent graft was inserted using a 0.035-inch
guidewire.

Figure 2. A preoperative conventional angiography image
showing a popliteal aneurysm.

with symptoms of thrombosis or claudication, and
secondary interventions were planned. All patients were
given 75mg clopidogrel and 100mg acetylsalicylic acid
during the postoperative period.
2.4. Statistical analysis
Statistical analysis was performed using SPSS for Windows
version 17.0 software (SPSS Inc., Chicago, IL, USA).
Descriptive data were expressed in mean ± standard
deviation (SD), median (interquartile range), or number
and frequency. The Fisher’s exact test and Chi-square
test were used to analyze significant differences between
variables. The Kolmogorov–Smirnov test was used to
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test whether the variables were normally distributed. An
independent samples t-test was used to determine whether
there was a statistically significant difference in normally
distributed data, while the Mann–Whitney U test was
carried out for nonnormally distributed data. A P value
of <0.05 was considered statistically significant with 95%
confidence interval (CI).
2. Results
Of all patients, 57 (90.5%) were males and six (9.5%) were
females with a mean age of 76.35 ± 7.46 (range, 45 to 88)
years. At the time of admission, 24 patients (38.1%) were
symptomatic, while 11 patients (17.5%) had a concomitant
AAA (abdominal aortic aneurysm). Baseline demographic
and clinical characteristics of the patients are shown in
Table 1.
The mean PAA diameter was 32.19 ± 5.98 mm.
Endovascular procedure was performed under local
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Table 1. Baseline demographic and clinical characteristics of the
patients.
Variable

n (%)

Male

57 (90.5)

Age, year (mean ± SD)

76.35 ± 7.46

Concomitant AAA

11 (17.5)

Hypertension

44 (69.8)

Smoking

51 (81.0)

Diabetes

9 (14.3)

CAD

18 (28.6)

Hyperlipidemia

39 (61.9)

COPD

16 (25.4)

Symptomatic
24 (38.1)
PAA diameter, mm (mean ±
32.19 ± 5.98
SD)
Aneurysm length, mm (mean
228.97 ± 40.24
± SD)
Number of distal arteries/
2.35 ± 0.72
patient (mean ± SD)
SD: standard deviation; AAA: abdominal aortic aneurysm; CAD:
coronary artery disease; COPD: chronic obstructive pulmonary
disease; PAA: popliteal artery aneurysm.
Table 2. Intraoperative data.

Figure 4. Postoperative elimination of aneurysm.

anesthesia in 53 patients, and access was maintained
through percutaneous route in 50 patients. The mean
number of stent grafts implanted was 1.55 ± 0.64. None
of the patients had any access site-related complications.
Intraoperative data are shown in Table 2.
The mean length of hospital stay was 1.92 ± 0.72 days.
No in-hospital mortality was seen, and no stent graft
thrombosis, migration, or fracture were observed within
30 days. The mean follow-up was 46.05 ± 25.01 months.
The primary patency rate was 79.3%. A graft thrombosis
was observed in 13 patients (20.6%) during a mean followup of 8.31 ± 5.91 months. Two patients (15.3%) with graft
thrombosis had stent graft fracture, while five patients
(7.9%) had thrombosis due to antiplatelet therapy cessation.
The patients with stent graft fracture underwent a second
intervention using additional stent grafts. However, five
patients with graft thrombosis in whom fibrinolysis therapy
failed underwent femoropopliteal bypass. Complete
patency was achieved in patients undergoing additional
stent graft insertion and fibrinolysis therapy. None of the

Variable

N (%)

Percutaneous access

50 (79.36)

Ipsilateral access

58 (92.06)

Local anesthesia

53 (84.12)

Contrast level (mean ± SD)
Number of stents/patient
(mean ± SD)
Length of stent, cm (mean
± SD)
Operation duration , min(
mean ± SD)
Technical success

47.30 ± 10.66
1.55 ± 0.64
9.05 ± 3.45
39.51 ± 7.44
63 (100)

SD: standard deviation.

patients needed amputation; however, five patients died
from several reasons and were excluded from the followup. The secondary patency rate was 84.12%. No endoleak
was observed during the follow-up (Table 3).
The mean PAA diameter was significantly higher,
and the mean number of tibioperoneal distal arteries was
significantly lower in the patients with graft thrombosis
than those without (P < 0.05). The mean number of distal
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arteries was 1.77 ± 0.83 and 2.50 ± 0.61 in the patients
with and without graft thrombosis, respectively (P < 0.05).
However, there was no significant difference in other
variables between the patients with and without graft
thrombosis (Table 4).
The mean PAA diameter and length and the mean
Table 3. Postoperative data.
Variable

n (%)

Follow-up, month (mean ± SD)

46.05 ± 25.01

Primary patency

50(79.3)

Graft thrombosis

13 (20.6)

Time to thrombosis, month (mean ± SD)

8.31 ± 5.91

Bypass

4(6.3)

Stent graft fracture

2(3.2)

Secondary patency

53(84.12)

Mortality

5(7.93)

Limb loss

0

Length of hospital stay, day (mean ± SD)

1.92 ± 0.72

SD: standard deviation.

number of stent grafts per patient were significantly
higher in the patients with AAA than those without (P
< 0.05). The mean PAA diameter was 37.98 ± 7.33 mm
and 30.97 ± 4.91 mm in the patients with AAA and those
without AAA, respectively (P < 0.05). In addition, the
ratio of symptomatic patients with AAA was significantly
higher than those without AAA (P < 0.05). All patients
were intravenously hydrated using 0.9% isotonic saline
after the procedure. None of the patients had acute renal
insufficiency (Table 5).
When the 63 patients included in the study were
analysed, 6mm stentgraft was used in 30 patients, 7mm
stentgraft was used in 22 patients, and 8mm stentgraft was
used in 11 patients. In all patients, 1 mm larger balloon
than stent graft was used for fixation and dilation. In the
study, stent thrombosis was seen in 13 patients. In 9 of
13 patients,had 6mm stentgraft and in the remaining 5
patients had 7mm stent graft with thrombosis.
3. Discussion
Popliteal artery aneurysms are the most common peripheral
artery aneurysms with an estimated incidence of 0.1 to
2.8% [10]. About 80% of PAAs asymptomatic at the time of
diagnosis and are often diagnosed incidentally; however,

Table 4. Comparison of demographic and clinical characteristics between patients with and without graft thrombosis.
Variable

Without thrombosis n = 50 With thrombosis n = 13 P

Male

45 (90.9)

12 (92.3)

0.639a

Age, year (mean ± SD)

77.14 ± 7.87

73.71 ± 4.66

0.099b

Abdominal aneurysm

8 (16.0)

3 (23.1)

0.405a

HT

34 (68.0)

10 (76.9)

0.398a

Smoking

40 (80.0)

11 (84.6)

0.528a

DM

7 (14.0)

2 (15.4)

0.599a

CAD

14 (28.0)

4 (30.8)

0.547a

Hyperlipidemia

30 (60.0)

9 (69.2)

0.392a

COPD

12 (24.0)

4 (30.8)

0.430a

Contrast level, cc (mean ± SD)

48.00 ± 9.90

44.61±13.30

0.312b

Aneurysm diameter, mm (mean ± SD)

20.10 ± 3.74

33.00 ± 6.21

0.007b

Aneurysm length, mm (mean ± SD)

229.65 ± 41.01

226.37 ± 38.59

0.796b

Number of distal arteries/patient [median (interquartile range)]

3(1)

2(1.50)

0.003c

Number of stents [median (interquartile range)]

1(1)

2(1)

0.122c

Length of stent, mm [median (interquartile range)]

9(5)

10(4)

0.867c

Follow-up duration, month [median (interquartile range)]

36(31.50)

70(57)

0.008c

Operation duration, min (mean ± SD)

40.70 ± 7.07

34.92 ± 7.31

0.011b

Length of hospital stay, day [median (interquartile range)]

2(0.25)

2(1)

0.412c

Fisher’s exact test, bIndependent samples t-test, and cMann–Whitney U test. SD: standard deviation; HT: hypertension; DM: diabetes
mellitus; CAD: coronary artery disease; COPD: chronic obstructive pulmonary disease.
a
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Table 5. Comparison of demographic and clinical characteristics between patients with and without abdominal aortic aneurysms.
Parameter

Without AAA n = 52

With AAA n = 11

P

Male

49 (94.2)

8 (72.7)

0.060a

Age, year (mean ± SD)

75.88 ± 7.62

78.54 ± 6.52

0.286b

Thrombosis

10 (19.2)

3 (27.3)

0.405a

HT

34 (65.4)

10 (90.9)

0.089a

Smoking

42 (80.8)

9 (81.8)

0.652a

DM

7 (13.5)

2 (18.2)

0.495a

CAD

12 (23.1)

6 (54.5)

0.046a

Hyperlipidemia

28 (53.8)

11 (100.0)

0.003a

COPD

11 (21.2)

5 (45.5)

0.100a

Symptomatic

14 (26.9)

10 (90.9)

0.000a

Contrast level, cc (mean ± SD)

46.83 ± 11.29

49.54 ± 6.87

0.447b

Aneurysm diameter, mm (mean ± SD)

30.97 ± 4.91

37.98 ± 7.33

0.000b

Aneurysm length, mm (mean ± SD)

222.05 ± 35.50

261.66 ± 46.75

0.002b

Number of distal arteries/patient [median (interquartile range)]

3(1)

2(1)

0.222c

Number of stents [median (interquartile range)]

1(1)

2(2)

0.046c

Length of stent, mm [median (interquartile range)]

8(3)

15(10)

0.134c

Follow-up duration, month [median (interquartile range)]

36(34.50)

66(50)

0.059c

Operation duration, min (mean ± SD)

39.31 ± 7.14

40.45 ± 9.07

0.646b

Thrombosis duration, month (mean ± SD)

8.30 ± 6.13

8.33 ± 6.35

0.994b

Length of hospital stay, day [median (interquartile range)]

2(0)

2(1)

0.143c

Fisher’s exact test, bIndependent samples t-test, cMann–Whitney U test, and dChi-square test (odds ratio). SD: standard deviation;
AAA: abdominal aortic aneurysm; HT: hypertension; DM: diabetes mellitus; CAD: coronary artery disease; COPD: chronic obstructive
pulmonary disease.
a

asymptomatic PAAs become symptomatic at a rate of 14%
per year. [11] Symptomatic PAA may resemble acute or
chronic limb ischemia, knee pain, nerve entrapment or
vein pressure. In general, an aneurysm diameter of >20
mm is an indication for surgery in asymptomatic cases
[12]. Ruptured or symptomatic PAAs should be treated
immediately. About 20% of asymptomatic cases are at risk
for limb loss due to late complications of PAA [13].
In the literature, there is still no consensus on the
optimal treatment of PAA. Conventional treatment
includes bypass surgery using an autologous saphenous
vein or synthetic graft. However, access-related
complications may occur in 30 to 40% of cases, indicating
a high perioperative morbidity rate [14]. In addition,
surgery is associated with postoperative complications
such as major amputation, major bleeding requiring a
second operation, nerve injury, deep vein thrombosis or
wound site infection [15–16]. Therefore, endovascular
technique offers more advantages than conventional
surgery in the treatment of PAA with shorter operation
duration and length of hospital stay, more rapid functional

recovery, minimal blood loss and wound site infection, and
avoidance of general anesthesia. Endovascular treatment,
however, is associated with stent graft occlusion, fracture,
or migration and endoleak; thus, it is still controversial
in the treatment of PAA. Popliteal artery aneurysms may
be bilateral and most of them present with aneurysms of
other anatomic locations. They are mostly seen in men
[6]. In our study, 90% of the patients were males and
17.5% of the patients had a concomitant AAA. Of note,
Dick Cheney, the vice president of the United States,
underwent endovascular stent grafting for bilateral PAA
in 2005 [17]. In the same year, Antonella et al. published
the first prospective, randomized study comparing open
surgery versus endovascular technique in the treatment
of PAA [14]. The authors found no statistically significant
difference in the four-year patency rates and limb salvage
between the two groups. Nonetheless, the authors
emphasized the advantages of endovascular treatment
with shorter length of hospital stay and rapid recovery. In
another study, the primary and secondary patency rates
were found to be 84.8% and 96.8%, respectively without

1111

TAYFUR and BADEMCİ / Turk J Med Sci
limb loss [18]. Piazza et al. [19] evaluated 47 patients with
PAA and reported a primary and secondary patency rate of
76% and 82%, respectively using endovascular technique.
Consistent with the literature, the primary and secondary
patency rates were 79.3% and 84.12%, respectively in our
study.
The popliteal region is constantly subjected to
movement and bending which may endanger of the
performance and durability of the stent graft. Therefore,
the stent graft to be chosen is of utmost importance. It
should be very flexible and resistant. In a study, heparincoated stent grafts yielded a significantly higher patency
rate than bare metal stents in the treatment of PAA
[20]. Similarly, the Viabahn stent graft is a composite
based on the combination of a thin, heparin-coated
polytetrafluoroethylene lining and a surrounding selfexpanding nitinol stent. In our study, a Viabahn stent graft
was inserted in all patients. Furthermore, a successful stent
graft implantation requires appropriate proximal and distal
landing zones and patent distal tibioperoneal arteries [21].
The evaluation of the distal arteries is critical to ensure the
durability of the endovascular repair, since the number
of patent distal arteries increases, the possibility of stent
occlusion decreases. The incidence of graft thrombosis
has been reported to be higher in patients with only one
patent distal artery than those with two or more patent
arteries [22]. In our study, the limited number of distal
arteries was significantly correlated with an increased rate
of graft thrombosis. The mean number of distal arteries
was 1.77 ± 0.83 and 2.50 ± 0.61 in the patients with and
without graft thrombosis, respectively. In a recent study,
the limited number of patent distal arteries was found to
be an independent risk factor for poor primary patency
rates. [23]
With the introduction of reports of Tielliu et al. [24]
in 2005, the use of postprocedural antiplatelet therapy
has become standard and has dramatically increased the
patency rates. In our study, five patients who discontinued
antiplatelet therapy within the first year developed
graft thrombosis. In addition, PAAs of <30 mm have a
lower complication rates [25]. Similarly, the mean PAA
diameter was significantly higher in the patients with graft
thrombosis in our study. It has been also well established
that increased aneurysm length is a disadvantage for
endovascular repair as it requires the use of more stent
grafts. In our study, although we used a higher number
of stent grafts in the patients with graft thrombosis, no
significant difference was found.
Review of the literature reveals limited data regarding
the relationship between PAAs and AAAs. In our study, 11
patients had a concomitant AAA. The mean PAA diameter
and length were significantly higher and the number of
stent grafts used was significantly greater in the patients
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with concomitant AAAs than those without. In addition,
10 of 11 patients (90.9%) were symptomatic, which reached
statistical significance.
Endovascular treatment of PAAs is associated with
serious complications, such as endoleak caused by reflux
of the blood into the aneurysmal sac through genicular
arteries. The incidence of such endoleaks is very low in
the literature [26–27]. Similarly, none of our patients had
endoleak. In addition, similar to our study, the rate of stent
occlusion has been estimated as low varying between 9
to 20% [18,22,28]. Graft thrombosis can be managed by
a second endovascular intervention, fibrinolytic therapy,
or surgical bypass. In general, stent graft thrombosis is
associated with a high rate of amputation; however, none
of our patients had limb loss, although the rate of graft
thrombosis was 20.6%, treated with a second endovascular
procedure. In a previous study comparing open surgery
and endovascular treatment in a large series, there was no
significant difference in the complication rates and 30- and
90-day mortality rates [29]. In recent years, endovascular
treatment of PAA using multi-layer flow-modulating
stents has been shown to be a safe and feasible method
[30,31].
Nonetheless, there are some limitations to this study.
Small sample size and nonrandomized, retrospective
design are the main limitations. In addition, patients
requiring emergency intervention due to acute limb
ischemia were excluded from the study. Therefore, no
results were obtained regarding the performance of the
graft used in this patient group. There are also some
prerequisites, such as diameter compliance, tortuosity,
and angulation suitability that should not be required in
the surgical treatment of popliteal artery aneurysms but
should be provided in the treatment of endovascular stent
grafts.
4. Conclusion
In conclusion, endovascular treatment of PAA using
appropriate stent grafts is safe in selected cases who are
at high risk for surgery due to comorbidities or those who
refuse surgery. It is also advantageous owing to its shorter
operation duration and length of hospital stay, more rapid
functional recovery, minimal blood loss and wound site
infection, and potential avoidance of general anesthesia.
The distal vascular bed and distal and proximal attachment
regions must be carefully examined before endovascular
treatment. It is reasonable to avoid endovascular treatment
due to an increased risk for thrombosis in patients with
a low number of patent distal arteries or impaired distal
flow. In addition, PAAs may present with concomitant
AAA and patients should be evaluated for possible AAAs.
Limb salvage is possible with a second endovascular
intervention even in patients with graft thrombosis.

TAYFUR and BADEMCİ / Turk J Med Sci
Acknowledgement/disclaimers/conflict of interest
The author(s) declared no financial support for the research
and authorship; no potential conflicts of interest with
respect to the research, authorship, and/or publication of
this article.

Informed consent
The necessary approval for our study has been granted by
the Ordu Provincial Health Directorate on the date of July
6th, 2020 with the protocol no 0012038785.

References
1.

Von Stumm M, Teufelsbauer H, Reichenspurner H, Debus
ES. Two decades of endovascular repair of popliteal artery
aneurysm. A meta-analysis. European Journal of Vascular
and Endovascular Surgery 2015; 50, 351-359. doi: 10.1016/j.
ejvs.2015.04.036

2.

Kropman RH, De Vries JP, Moll FL. Surgical and endovascular
treatment of atherosclerotic popliteal artery aneurysms. The
Journal of Cardiovascular Surgery (Torino) 2007; 48: 2 81-288.

3.

Rutherford RB. Arterial aneurysms. In: Cronenwett JL (editor).
Rutherford’s Vascular Surgery. 6th ed. Philadelphia, PA, USA:
Saunders; 2005. pp.1403-1408.

4.
5.

6.

7.

12.

Dawson J, Fitridge R. Update on aneurysm disease: current
insights and controversies: peripheral aneurysms: when to
intervene-is rupture really a danger? Progress in Cardiovascular
Diseases. 2013; 56: 26-35. doi: 10.1016/j.pcad.2013.05.002

13.

Whitehouse WM Jr, Wakefield TW, Graham LM, Kazmers A,
Zelenock GB et al. Limb – threatening potential of arteriosclerotic popliteal artery aneurysms. Surgery. 1983; 93: 694-699.

14.

Dawson I, Sie RB, Van Bockel JH. Atherosclerotic popliteal
aneurysm. The British Journal of Surgery 1997; 84: 293-299.

Antonello M, Frigatti P, Battocchio P, Lepidi S, Cognolato D
et al. Open repair versus endovascular treatment for asymptomatic popliteal artery aneurysm: results of a prospective randomized study. Journal of Vascular Surgery. 2005; 42: 185-193.
doi: 10.1016/j.jvs.2005.04.049

15.

Kropman, R. H. J., Schrijver, A. M., Kelder, J. C., Moll, F. L.,
De Vries, J. P. P. M Clinical outcome of acute leg ischemia due
to thrombosed popliteal artery aneurysm: systematic review
of 895 cases. European Journal of Vascular and Endovascular
Surgery 2010; 39: 452-457. doi:10.1016/j.ejvs.2009.11.010

Cervin A, Tjärnström J, Ravn H, Acosta S, Hultgren R et al.
Treatment of popliteal aneurysm by open and endovascular
surgery a contemporary study of 592 procedures in Sweden.
European Journal of Vascular and Endovascular Surgery. 2015;
50: 342-350. doi: 10.1016/j.ejvs.2015.03.026

16.

Wissgott C, Lüdtke CW, Vieweg H, Scheer F, Lichtenberg M et
al. Endovascular treatment of aneurysms of the popliteal artery
by a covered endoprosthesis. Clinical Medicine Insights. Cardiology. 2014; 8(Suppl 2): 15-21. doi: 10.4137/CMC.S15232

Serrano Hernando FJ, Martínez López I, Hernández Mateo
MM, Hernando Rydings M, Sánchez Hervás L et al. Comparison of popliteal artery aneurysm therapies. Journal of Vascular
Surgery 2015; 61: 655-661. doi: 10.1016/j.jvs.2014.10.007

17.

Nelson PR, Anthony Lee W. Endovascular treatment of popliteal artery aneurysms. Vascular. 2006; 14 (5): 297-304. doi:
10.2310/6670.2006.00049

18.

Idelchik GM, Dougherty KG, Hernandez E, Mortazavi A, Strickman NE et al. Endovascular exclusion of popliteal artery aneurysms with stent-grafts: a prospective single-center experience. Journal of Endovascular Therapy 2009; 16: 215-223. doi:
10.1583/08-2412.1

19.

Piazza M, Menegolo M, Ferrari A, Bonvini S, Ricotta JJ et al.
Long-term outcomes and sac volume shrinkage after endovascular popliteal artery aneurysm repair. European Journal
of Vascular and Endovascular Surgery 2014; 48: 161-168. doi:
10.1016/j.ejvs.2014.04.011

20.

Lammer J, Zeller T, Hausegger KA, Schaefer PJ, Gschwendtner M et al. Heparin-bonded covered stents versus bare-metal
stents for complex femoropopliteal artery lesions: the randomized VIASTAR trial (Viabahn endoprosthesis with PROPATEN bioactive surface (VIA) versus bare nitinol stent in the
treatment of long lesions in superficial femoral artery occlusive
disease). Journal of the American College of Cardiology 2013;
62: 1320-1327. doi: 10.1016/j.jacc.2013.05.079

Marin ML, Veith FJ, Panetta TF, Cynamon J, Bakal CW et al.
Transfemoral endoluminal stented graft repair of a popliteal
artery aneurysm. Journal of Vascular Surgery. 1994; 19 (4):
754-757. doi: 10.1016/s0741-5214(94)70052-4

8.

Wain RA, Hines G. A contemporary review of popliteal artery
aneurysms. Cardiology in Review. 2007; 15 (2): 102-107. doi:
10.1097/01.crd.0000220212.52649.4a

9.

Curi MA, Geraghty PJ, Merino OA, Veeraswamy RK, Rubin
BG et al. Mid-term outcomes of endovascular popliteal artery
aneurysm repair. Journal of Vascular Surgery. 2007; 45 (3):
505-510. doi: 10.1016/j.jvs.2006.09.064

10.

Gawenda M, Sorgatz S, Müller U, Walter M, Erasmi H. The
thrombosed popliteal artery aneurysm and distal arterial
occlusion: successful therapy by interdisciplinary management.
The Thoracic and Cardiovascular Surgeon. 1995; 43: 112-126.
doi: 10.1055/s-2007-1013782

11.

Cross JE, Galland RB. Part one: for the motion asymptomatic
popliteal artery aneurysms (less than 3 cm) should be treated
conservatively. European Journal of Vascular and Endovascular Surgery. 2011; 41: 445-448. doi: 10.1016/j.ejvs.2011.02.007

1113

TAYFUR and BADEMCİ / Turk J Med Sci
21.

Siauw R, Koh EH, Walker SR. Endovascular repair of popliteal
artery aneurysms: techniques,current evidence and recent experience. Australian and New Zealand Journal of Surgery 2006;
76: 505-511. doi: 10.1111/j.1445-2197.2006.03745.x

27.

Midy D, Berard X, Ferdani M, Alric P, Brizzi V et al. A Retrospective multicenter study of endovascular treatment of popliteal artery aneurysm. Journal of Vascular Surgery 2012; 51:
850-856. doi: 10.1016/j.jvs.2009.10.107

22.

Garg, K., Rockman, C. B., Kim, B. J., Jacobowitz, G. R., Maldonado, T. S et al. Outcome of endovascular repair of popliteal artery aneurysm using the Viabahn endoprothesis. Journal
of Vascular Surgery 2012; 55 (6): 1647-1653. doi: 10.1016/j.
jvs.2011.12.059

28.

Stone PA, Jagannath P, Thompson SN, Campbell JE, Mousa AY
et al. Evolving treatment of popliteal artery aneurysms. Journal of Vascular Surgery 2013; 57: 1306-1310. doi: 10.1016/j.
jvs.2012.10.122

29.

23.

Hernando, F. J. S., López, I. M., Mateo, M. M. H., Rydings, M.
H., Hervás, L et al. Comparison of popliteal artery aneurysm
therapies. Journal of Vascular Surgery 2015; 61: 655-661. doi:
10.1016/j.jvs.2014.10.007

Galiñanes EL, Dombrovskiy VY, Graham AM, Vogel TR. Endovascular versus open repair of popliteal artery aneurysms:
outcomes in the US Medicare population. European Journal
of Vascular and Endovascular Surgery 2013; 47: 267-273. doi:
10.1177/1538574413475888

24.

Tielliu IF, Verhoeven EL, Zeebregts CJ, Prins TR, Span MM et
al. Endovascular treatment of popliteal artery aneurysms: results of a prospective cohort study. Journal of Vascular Surgery
2005; 41: 561-567. doi: 10.1016/j.jvs.2004.12.055

30.

Ucci A, Curci R, Azzarone M, Bianchini Massoni C, Bozzani A
et al. Early and mid-term results in the endovascular treatment
of popliteal aneurysms with the multilayer flow modulator. Vascular 2018; 26 (5): 556-563. doi: 10.1177/1708538118771258

25.

Galland RB, Magee TR. Popliteal aneurysms: distortion and
size related to symptoms. Journal of Vascular and Endovascular
Surgery 2005; 30 (5): 534-538. doi: 10.1016/j.ejvs.2005.05.021

31.

26.

Antonello M, Frigatti P, Battocchio P, Lepidi S, Dall’Antonia
A et al. Endovascular treatment of asymptomatic popliteal
aneurysm:8-year concurrent comparison with open repair. The
Journal of Cardiovascular Surgery (Torino) 2007; 48 (3): 267274.

Elif Coşkun, Levent Altınay, Anıl Tekin, Ufuk Tütün. Endovascular treatment of popliteal artery aneurysms: A report of three
cases. Turkish Journal of Vascular Surgery 2020; 29 (1): 59-62.
doi: 10.9739/tjvs.2020.258

1114

